Hannover Rueck SE (HNRB) AI Stock Analysis
Hannover Rueck SE
(Frankfurt:HNRB)
No summary available
Hannover Rueck SE (HNRB) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 39.11B
- Dividend Yield
- 4.46%
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 3.8
- Beta (1Y)
- 0.39
- Revenue Growth
- -2.14%
- EPS Growth
- 10.15%
- Country
- Germany
- Employees
- 4,078
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Insurance - Reinsurance
Hannover Rueck SE Business Overview & Revenue Model
Company Description
Hannover Rück SE, through its network of global subsidiaries, functions as a prominent international supplier of extensive reinsurance solutions and related services. Its business operations are primarily divided into two main areas: Property & Casua...
Hannover Rueck SE Earnings Call Summary
The call conveyed strong operational and financial results: solid group net income (EUR 1.4bn), P&C combined ratio well inside target (83.2%), ROI above target (3.7%), robust solvency (254%) and significant premium/CSM growth across business lines. Management acknowledged market headwinds — notably rate softening (risk-adjusted price decline ~4%), structured reinsurance volume reductions, IFRS 17 reporting effects on revenue, and localized claim/assumption pressures in Life & Health — but emphasized prudent reserving, ample large-loss buffers (~EUR 1.5bn remaining), and confidence in delivering 2026 guidance. Overall, the positives (profitability, capital strength, growth in renewals/CSM and investment yield) outweigh the challenges, with management framing the negatives as manageable and addressed through underwriting discipline and reserve prudence.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management confirmed unchanged 2026 guidance, noting strong H1 metrics that keep the group on track: group net income of EUR 1.4bn YTD, P&C combined ratio 83.2% (well inside the <87% target, despite fully booking the large‑loss budget), H1 ROI 3.7% (above the 3.5% target), solvency ratio 254%, operating capital generation ~EUR 1.8bn and shareholders’ equity +2.6%; commercial momentum included year‑to‑date compound renewal premium growth +7.2%, underlying traditional premium growth ~4% (traditional treaty volume +12.3% at mid‑year) with a risk‑adjusted price change of -4.5% (traditional portfolio -3.9% YTD), P&C new business CSM EUR 1.7bn and Life & Health new CSM EUR 385m (L&H reinsurance service result EUR 478m, already >50% of the ~EUR 925m full‑year target), CSM growth +11.4% and risk adjustment +5.8%; management also highlighted more than EUR 200m of unused large‑loss budget in H1 and about EUR 1.5bn of remaining large‑loss capacity for the rest of the year.
Hannover Rueck SE Peers Comparison
Overall Rating
RGA78Outperform
RNR76Outperform
SPNT76Outperform
HG75Outperform
EG65Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 78Outperform | $17.29B | 11.50 | 11.29% | 1.42% | 19.54% | 97.85% | |
| 76Outperform | $13.71B | 9.66 | 14.82% | 0.48% | -21.18% | -3.27% | |
| 76Outperform | $3.01B | 6.24 | 21.84% | ― | 22.55% | 371.77% | |
| 75Outperform | $3.44B | 6.58 | 23.92% | ― | 19.62% | 22.42% | |
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 65Neutral | $15.76B | 8.75 | 12.52% | 1.95% | -8.72% | 250.85% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:HNRB | Hannover Rueck SE (ADR) | 46.80 | 7.29 | 18.45% | |
| EG | Everest Group, Ltd. | 410.97 | 104.95 | 34.30% | |
| RGA | Reinsurance Group Of America | 264.73 | 86.33 | 48.39% | |
| RNR | Renaissancere | 339.32 | 84.73 | 33.28% | |
| SPNT | Siriuspoint Ltd | 25.88 | 7.00 | 37.08% | |
| HG | Hamilton Insurance Group, Ltd. Class B | 35.06 | 13.34 | 61.43% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.